Cargando…

The Related Metabolic Diseases and Treatments of Obesity

Obesity is a chronic disease characterized by the abnormal or excessive accumulation of body fat, affecting more than 1 billion people worldwide. Obesity is commonly associated with other metabolic disorders, such as type 2 diabetes, non-alcoholic fatty liver disease, cardiovascular diseases, chroni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Ming, Liu, Shuai, Zhang, Chunye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498506/ https://www.ncbi.nlm.nih.gov/pubmed/36141228 http://dx.doi.org/10.3390/healthcare10091616

Ejemplares similares

Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options
por: Zhang, Chunye, et al.
Publicado: (2021)

The Emerging Factors and Treatment Options for NAFLD-Related Hepatocellular Carcinoma
por: Zhang, Chunye, et al.
Publicado: (2021)

Current Options and Future Directions for NAFLD and NASH Treatment
por: Zhang, Chunye, et al.
Publicado: (2021)

Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
por: Zhang, Chunye, et al.
Publicado: (2021)

The role of iron metabolism in chronic diseases related to obesity
por: Qiu, Fangyi, et al.
Publicado: (2022)

Antimicrobial Peptides: From Design to Clinical Application
por: Zhang, Chunye, et al.
Publicado: (2022)

Newly Emerged Antiviral Strategies for SARS-CoV-2: From Deciphering Viral Protein Structural Function to the Development of Vaccines, Antibodies, and Small Molecules
por: Zhang, Chunye, et al.
Publicado: (2022)

The Impact of Phytochemicals in Obesity-Related Metabolic Diseases: Focus on Ceramide Metabolism
por: Kim, Eunkyeong, et al.
Publicado: (2023)

Anti-Viral Activity of Bioactive Molecules of Silymarin against COVID-19 via In Silico Studies
por: Zhang, Chunye, et al.
Publicado: (2023)

Brown Fat and Browning for the Treatment of Obesity and Related Metabolic Disorders
por: Kim, So Hun, et al.
Publicado: (2016)

The Role and Potential Application of Antimicrobial Peptides in Autoimmune Diseases
por: Zhang, Chunye, et al.
Publicado: (2020)

Obesity-Related Chronic Kidney Disease—The Role of Lipid Metabolism
por: Mount, Peter, et al.
Publicado: (2015)

In silico drug repurposing carvedilol and its metabolites against SARS-CoV-2 infection using molecular docking and molecular dynamic simulation approaches
por: Zhang, Chunye, et al.
Publicado: (2023)

Iron Metabolism in Aging and Age-Related Diseases
por: Tian, Yao, et al.
Publicado: (2022)

The Genetic Basis of Obesity and Related Metabolic Diseases in Humans and Companion Animals
por: Wallis, Natalie, et al.
Publicado: (2020)

The Potential Gut Microbiota-Mediated Treatment Options for Liver Cancer
por: Zhang, Chunye, et al.
Publicado: (2020)

Sinapic Acid and Its Derivatives as Medicine in Oxidative Stress-Induced Diseases and Aging
por: Chen, Chunye
Publicado: (2016)

Intestinal microbiota in the treatment of metabolically associated fatty liver disease
por: Wang, Ji-Shuai, et al.
Publicado: (2022)

MicroRNAs in Obesity and Related Metabolic Disorders
por: Landrier, Jean-François, et al.
Publicado: (2019)

Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment
por: Ding, Yuping, et al.
Publicado: (2023)

Function of Macrophages in Disease: Current Understanding on Molecular Mechanisms
por: Zhang, Chunye, et al.
Publicado: (2021)

Emerging concepts in intestinal immune control of obesity-related metabolic disease
por: Khan, Saad, et al.
Publicado: (2021)

Glycine Metabolism and Its Alterations in Obesity and Metabolic Diseases
por: Alves, Anaïs, et al.
Publicado: (2019)

Pattern Recognition Receptor-Mediated Chronic Inflammation in the Development and Progression of Obesity-Related Metabolic Diseases
por: Yu, Lili, et al.
Publicado: (2019)

Consideration of Gut Microbiome in Murine Models of Diseases
por: Zhang, Chunye, et al.
Publicado: (2021)

Gut and obesity/metabolic disease: Focus on microbiota metabolites
por: Lin, Ke, et al.
Publicado: (2022)

Nutritional Counseling for Obese Children with Obesity-Related Metabolic Abnormalities in Korea
por: Kang, Ki Soo
Publicado: (2017)

The role of oxidative stress in the development of obesity and obesity-related metabolic disorders
por: Čolak, Emina, et al.
Publicado: (2021)

Impact of Obesity-Related Inflammation on Cardiac Metabolism and Function
por: Larsen, Terje S., et al.
Publicado: (2021)

Effects of dietary vitamins on obesity-related metabolic parameters
por: Lee, Chooi Yeng
Publicado: (2023)

Infections and immunity: associations with obesity and related metabolic disorders
por: Ray, Amitabha, et al.
Publicado: (2023)

Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer
por: Cheng, Can, et al.
Publicado: (2019)

Synbiotic Supplements in the Prevention of Obesity and Obesity-Related Diseases
por: Hijová, Emília
Publicado: (2022)

Obesity, DNA Damage, and Development of Obesity-Related Diseases
por: Włodarczyk, Marta, et al.
Publicado: (2019)

Role of microRNAs in obesity and obesity-related diseases
por: Iacomino, Giuseppe, et al.
Publicado: (2017)

Epigenetic regulation of energy metabolism in obesity
por: Gao, Wei, et al.
Publicado: (2021)

Obesity and Metabolic Comorbidities: Environmental Diseases?
por: Lubrano, Carla, et al.
Publicado: (2013)

Amino Acid-Related Metabolic Signature in Obese Children and Adolescents
por: Polidori, Nella, et al.
Publicado: (2022)

Obesity-Related Changes in High-Density Lipoprotein Metabolism and Function
por: Stadler, Julia T., et al.
Publicado: (2020)

Obesity-Related Metabolic Dysfunction in Dairy Cows and Horses: Comparison to Human Metabolic Syndrome
por: Daradics, Zsofia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_630dfa8r2r44l58qcpehqt1tkv